# MABVAX THERAPEUTICS HOLDINGS, INC.

MABVAX THERAPEUTICS HOLDINGS, INC. is a company headquartered in San Diego, CA, United States.

## Company overview

- **Legal name:** MABVAX THERAPEUTICS HOLDINGS, INC.
- **Former names in filing history:** TELIK INC (2000-07-03 to 2014-09-09)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** San Diego, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001109196

## About

MABVAX THERAPEUTICS HOLDINGS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001109196, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2018-04-02, it reported annual revenue of USD 0; net income of USD -19,020,679; total assets of USD 8,790,324 for the fiscal period ended 2017-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2017 (period ended 2017-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$19.0M (USD -19,020,679)
- **Total assets:** $8.8M (USD 8,790,324)
- **Cash and equivalents:** $885,710 (USD 885,710)
- **Operating cash flow:** $11.0M (USD 10,995,509)

### FY2016 (period ended 2016-12-31)

- **Revenue:** $148,054 (USD 148,054)
- **Net income:** -$17.7M (USD -17,660,483)
- **Total assets:** $12.0M (USD 12,020,290)
- **Cash and equivalents:** $4.0M (USD 3,979,290)
- **Operating cash flow:** -$12.4M (USD -12,363,411)

### FY2015 (period ended 2015-12-31)

- **Revenue:** $1.3M (USD 1,267,036)
- **Net income:** -$18.1M (USD -18,105,315)
- **Total assets:** $12.4M (USD 12,397,127)
- **Cash and equivalents:** $4.1M (USD 4,084,085)
- **Operating cash flow:** -$10.5M (USD -10,525,182)

### FY2014 (period ended 2014-12-31)

- **Revenue:** $314,175 (USD 314,175)
- **Net income:** -$7.9M (USD -7,917,853)
- **Total assets:** $8.8M (USD 8,804,864)
- **Cash and equivalents:** $1.5M (USD 1,477,143)
- **Operating cash flow:** -$7.7M (USD -7,662,019)

## Recent SEC filings

- Form 8-K — filed 2019-03-25 — period 2019-03-21 — CURRENT REPORT
- Form 8-K — filed 2019-01-04 — period 2019-01-03 — CURRENT REPORT
- Form S-1 — filed 2018-11-20 — REGISTRATION STATEMENT ON FORM S-1
- Form 8-K — filed 2018-11-20 — period 2018-11-19 — CURRENT REPORT
- Form 10-Q — filed 2018-11-13 — period 2018-09-30 — QUARTERLY REPORT
- Form 8-K — filed 2018-10-22 — period 2018-10-22 — CURRENT REPORT
- Form 8-K — filed 2018-10-16 — period 2018-10-16 — CURRENT REPORT
- Form 10-Q — filed 2018-10-15 — period 2018-06-30 — QUARTERLY REPORT
- Form 10-Q — filed 2018-10-15 — period 2018-03-31 — QUARTERLY REPORT
- Form 10-K/A — filed 2018-10-15 — period 2017-12-31 — 10-K/A
- Form SC 13G — filed 2018-08-06
- Form 8-K — filed 2018-07-09 — period 2018-07-06

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/mabvax-therapeutics-holdings-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology